BIO Lauds Signing of JOBS Act into Law

Apr 5 2012
The Biotechnology Industry Organization expressed strong support for the signing of the Jumpstart Our Business Startups (JOBS) Act into law today.

Farm Bill Energy Title Reauthorization Critical for Energy Independence and Continued U.S. Innovation, BIO Says

Apr 5 2012
BIO joined 100 renewable energy, energy efficiency, farm, ranch, commodity, environmental, and other groups in a letter to the leaders of the House and Senate Agriculture Committees asking for reauthorization and funding of Farm Bill energy title programs.

Execs From Coca Cola, United Airlines, Goodyear and Chrysler Among Speakers at 2012 World Congress on Industrial Biotechnology

Apr 5 2012
Executives from brand-name consumer product companies will discuss the strategies for adoption of industrial biotech innovations in plenary and breakout sessions at BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing.

Orphan Diseases and the Future of BioPharma, the Focus of the 2012 Orphan Disease Forum

Apr 5 2012
Centric Health Resources and the National Organization for Rare Disorders (NORD), Co-organizersAlnylam Pharmaceuticals, Genzyme, a Sanofi Company and Millennium: The Takeda Oncology Company, Co-sponsors

The Military’s Commitment to Biofuels Is a National Security Imperative, BIO Says

Mar 29 2012
Domestic biofuel production is necessary for energy and national security, the Biotechnology Industry Organization (BIO) emphasized today in a letter to the leaders of the House Armed Services Committee and its Subcommittee on Readiness. 

BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA

Mar 29 2012
Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization (BIO), testified today on biosimilar user fees (BsUFA) and the Prescription Drug User Fee Act (PDUFA) before the Senate Health, Education, Labor and Pensions Committee.

BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children

Mar 28 2012
H.R. 4274 will encourage continued investment in pediatric research.

BIO Announces Novozymes CEO and President Steen Riisgaard as its 2012 George Washington Carver Award Recipient

Mar 28 2012
BIO has named Steen Riisgaard as the recipient of its 2012 George Washington Carver Award for innovation in industrial biotechnology.

BIO Opens Nominations for 2012 Biotech Humanitarian Award

Mar 28 2012
Annual Award to Recognize Innovator Who Is Transforming Society byHelping to Heal, Feed or Fuel the World 

BIO Applauds Congress for Passage of the Jumpstart Our Business Startups (JOBS) Act

Mar 27 2012
The JOBS Act will incentivize and encourage capital formation for growing companies, and spur job growth in the U.S.